Zobrazeno 1 - 10 of 32 pro vyhledávání: '"Dale R. Spriggs"'
1
Public Health Considerations for the Use of Cholera Vaccines in Cholera Control Programs
Autor: Dale R. Spriggs, David A. Sack, John D. Clemens
Publikováno v: #N# Vibrio cholerae and Cholera
Conventional parenteral cholera vaccines have largely been abandoned as public health tools, and recent studies have elucidated the probable reason for their poor performance. This chapter reviews the reasons that older parenteral cholera vaccines ha
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::303890ab5387a1119afdba7dc0da6287
https://doi.org/10.1128/9781555818364.ch28
Zobrazit plný text záznamu
2
Efficacy of live, attenuated, human rotavirus vaccine 89–12 in infants: a randomised placebo-controlled trial
Autor: Keith S. Reisinger, Edward P. Rothstein, Dale R. Spriggs, Richard L. Ward, David I. Bernstein, Donna O'Sullivan, Vicki E. Smith, David A. Sack
Publikováno v: The Lancet. 354:287-290
Summary Background Rotavirus is the most common cause of severe, dehydrating diarrhoea in infants worldwide. We assessed the safety, immunogenicity, and efficacy of a live, oral human rotavirus vaccine, 89–12, in US children in a randomised, placeb
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::420857ec3a73403080d015acdbf237fa
https://doi.org/10.1016/s0140-6736(98)12106-2
Zobrazit plný text záznamu
3
Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12
Autor: Richard L. Ward, Gilbert M. Schiff, Dale R. Spriggs, Donna S. Sander, Donna DeFeudis, David I. Bernstein, Vicki E. Smith, James R. Sherwood
Publikováno v: Vaccine. 16:381-387
The safety and immunogenicity of an orally administered live human rotavirus vaccine candidate (89-12), attenuated by 33 passages in monkey kidney cells, were evaluated in placebo-controlled trials in adults, children and infants. This strain was sel
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04c972edf3f0179c50d0f058c93eba85
https://doi.org/10.1016/s0264-410x(97)00210-7
Zobrazit plný text záznamu
4
From the National Institute of Allergy and Infectious Diseases. Summary of the 27th United States-Japan Joint Conference on Cholera and Related Diarrheal Diseases
Autor: Richard L. Guerrant, Dale R. Spriggs
Publikováno v: Journal of Infectious Diseases. 167:1-6
The 31 st United States-Japan Cholera and Related Diarrheal Diseases Conference was held in conjunction with the United States-Japan Malnutrition Conference at Kiawah Island, South Carolina, 30 November to 3 December 1995. In addition to the overall
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6b9cdaf5a9ed3d1fa7df6a7c576346e9
https://doi.org/10.1093/infdis/167.1.1
Zobrazit plný text záznamu
6
Evaluation of Peru-15, a new live oral vaccine for cholera, in volunteers
Autor: Karen Metcalfe, Janet Shimko, George Gomes, Dale R. Spriggs, R. Bradley Sack, David A. Sack, Donna O'Sullivan
Publikováno v: The Journal of infectious diseases. 176(1)
A new live oral cholera vaccine, Peru-15, was studied for safety, immunogenicity, and excretion in 2 groups of healthy volunteers. Twelve inpatient volunteers received freshly harvested vaccine in doses of either 10 7 or 10 9 cfu. Subsequently 50 out
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1aac483fa92f0e7219d6ec3d271051c5
https://pubmed.ncbi.nlm.nih.gov/9207368
Zobrazit plný text záznamu
7
Peru-15, an improved live attenuated oral vaccine candidate for Vibrio cholerae O1
Autor: Trinka S. Coster, Dale R. Spriggs, Andrew F. Trofa, John J. Mekalanos, Jennifer Adams, David N. Taylor, Kevin P. Killeen, Maria Barrera-Oro, Julie R. Kenner, Tracy Hyman, Beattie David, Jerald C. Sadoff
Publikováno v: The Journal of infectious diseases. 172(4)
Cholera vaccine candidate Peru-15 was derived from a Vibrio cholerae O1 El Tor Inaba strain by deleting the cholera toxin genetic element, introducing the gene encoding cholera toxin B subunit into recA, and screening for nonmotility. In a controlled
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8ac099a7c64047be6b56b6417f5de90
https://pubmed.ncbi.nlm.nih.gov/7561195
Zobrazit plný text záznamu
9
Identification of the major structural proteins of two BALB/c myeloma C-type viruses
Autor: Robert G. Krueger, Dale R. Spriggs
Publikováno v: Virology. 98:35-44
We have analyzed the structural proteins of the C-type viruses produced by cloned lines of the MOPC-21 and FLOPC-1 BALB/c murine myelomas. These viruses, designated MO 21 -MuMAV and FL 1 -MuMAV, respectively, have been shown to be composed of protein
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddbf839271dd5f09de891c9eeee3aa9a
https://doi.org/10.1016/0042-6822(79)90522-1
Zobrazit plný text záznamu
10
Genetic basis for altered pathogenesis of an immune-selected antigenic variant of reovirus type 3 (Dearing)
Autor: Kenneth M. Kaye, Dale R. Spriggs, B N Fields, Rhonda S Bassel-Duby, Kenneth L. Tyler
Publikováno v: Journal of Virology. 59:90-97
In this paper we provide a step by step comparison of the pathogenesis of murine infection caused by reovirus type 3 (Dearing) and an antigenic variant (K) selected by its resistance to neutralization with a monoclonal antibody (G5) directed against
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62bddd6134399b8020c9fa4e65416893
https://doi.org/10.1128/jvi.59.1.90-97.1986
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje